Jason Cong Selected Research

Plasminogen Activator Inhibitor 1

1/2019

Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason Cong Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Triple Negative Breast Neoplasms 01/2019

Drug/Important Bio-Agent (IBA)

1	NAD (NADH)IBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	CollagenIBA 01/2019
1	Hormones (Hormone)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2019